IONS

Ionis Pharmaceuticals, Inc.

IONS · CIK 874015 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$203M
20182025
Net Income−$229M
20182025
Operating CF−$269M
20182025
Free Cash Flow−$320M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.2B$0.2B$0.3B$0.2B$0.4B$0.3B$0.5B$0.2B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Gross Profit————————
R&D Expense$0.9B———$0.6B$0.5B$0.5B$0.4B
SG&A Expense$0.4B$0.3B$0.2B$0.2B$0.2B$0.4B$0.3B$0.2B
Operating Income$-0.2B$-0.1B$-0.0B$-0.2B$0.2B$-0.0B$0.3B$0.0B
Net Income$-0.2B$-0.1B$-0.0B$-0.3B$0.2B$-0.3B$0.2B$0.3B
EPS (Basic)$-1.41$-0.66$-0.06$-0.37$1.59$-2.44$1.31$2.32
EPS (Diluted)$-1.41$-0.66$-0.06$-0.37$1.41$-2.44$1.28$2.21

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$3.5B$3.0B$3.0B$2.5B$2.6B$2.4B$3.2B$2.7B
Current Assets$3.0B$2.6B$2.6B$2.2B$2.3B$2.1B$2.7B$2.2B
Cash & Equivalents$0.4B$0.2B$0.4B$0.3B$0.9B$0.4B$0.7B$0.3B
Total Liabilities$3.0B$2.4B$2.6B$2.0B$1.8B$1.5B$1.5B$1.5B
Current Liabilities$0.8B$0.3B$0.4B$0.3B$0.2B$0.6B$0.3B$0.3B
Stockholders' Equity$0.5B$0.6B$0.4B$0.6B$0.8B$0.8B$1.5B$1.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$-0.3B$-0.5B$-0.3B$-0.3B$0.0B$0.0B$0.3B$0.6B
Investing Cash Flow$-0.3B$-0.1B$-0.2B$-0.3B$0.2B$0.3B$-0.0B$-0.9B
Capital Expenditures$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.7B$0.5B$0.6B$-0.1B$0.2B$-0.6B$0.1B$0.5B
← Companies